Rigaku Announces New Tagline ~POWERING NEW PERSPECTIVES~

Rigaku Corporation (Head Office: Akishima, Tokyo; President: Toshiyuki Ikeda; hereafter "Rigaku"), a leading manufacturer of X-ray analysis and inspection equipment, announces that it has launched a new slogan and a fresh approach to the market after 70 years of bringing innovation to the global scientific community. Since its founding, Rigaku, together with its group companies [...]

Sekkei Bio Implements CDD Vault to Centralize Research Data

San Francisco and Bangalore — Collaborative Drug Discovery (CDD) announced today that Sekkei Bio, an India-based company dedicated to building cutting-edge technologies for drug and vaccine design with global impact, has implemented CDD Vault as the main platform to house its research data. Sekkei has made big progress toward finding therapies for diabetes and pain. Sekkei Bio [...]

ViQi, Inc. announces Pascal Bamford, Ph.D. and Timothy Spicer, Ph.D. have joined the board of directors and scientific advisory board, respectively

ViQi, Inc, a California cloud-based image analysis company specializing in using artificial intelligence for the scientific discovery process, is excited to announce the appointment of Pascal Bamford, Ph.D. to the board of directors and Timothy Spicer, Ph.D. as the inaugural member of the scientific advisory board. SANTA BARBARA, Calif. - ViQi, Inc, a California cloud-based image analysis company specializing [...]

AgiLab Joins the Tetra Partner Network to Accelerate Efficiency and Maximize Quality Control Processes for Biopharma Customers

BOSTON, Mass. – TetraScience, the Scientific Data Cloud company, announced today that AgiLab, provider of a unified laboratory digital platform, has joined the Tetra Partner Network to help biopharmaceutical customers accelerate R&D efficiency and maximize quality control processes with the Tetra Scientific Data Cloud(™). “We’re delighted to partner with AgiLab, who share our commitment to maximize [...]

Thermo Fisher Scientific’s PPD Clinical Research Business Selected to Support National Cancer Institute’s Cancer Trials Support Unit

Opportunity to provide digital data and decentralized trial services for multi-institutional cancer trials led by NCI-supported organizations WILMINGTON, N.C. -- The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a 10-year Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract by the National Cancer Institute (NCI), part of the National Institutes of [...]

Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight

Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfully completed extended concordance testing on Olink’s platforms (Olink® Target 48/96 and Olink® Explore), fulfilling specific requirements that supplement the Olink quality acceptance criteria. This latest validation was initiated by and implemented in cooperation with a leading global [...]

ZEISS microscope developers nominated for 2022 German Future Prize

ZEISS Lattice Lightsheet 7 enables the gentle 3D imaging of living cells Jena / Munich, Germany -- Today, the Office of the Federal President announced the nominations for the German Future Prize (Deutscher Zukunftspreis) at the German Museum in Munich. ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen and Ralf Wolleschensky have been nominated for [...]

QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN’s NGS testing portfolio for precision medicine beyond oncology into neurology applications HILDEN, Germany & GERMANTOWN Md. & SOUTH SAN FRANCISCO, Calif. -- QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and Neuron23 Inc., an early stage [...]

GTT TAKES A MINORITY INTEREST IN TUNABLE AS, A HIGHLY INNOVATIVE NORWEGIAN START-UP SPECIALISED IN MULTI-GAS & EMISSIONS ANALYSERS

Paris - GTT announces it has taken a minority stake in the Norwegian technology start-up Tunable AS, via a €6.4 million investment round co-led with TRUMPF Venture, with the participation of the company's existing shareholders. Tunable AS designs and manufactures compact multi-gas analysers based on MEMS[1] technology, combining micro and nanotechnology with infrared spectroscopy[2]. The sensors developed [...]

Gemini BioProducts Announces Addition to Board of Directors

Cory Stevenson, former President of the BioProduction division at Thermo Fisher Scientific joins Board FORT LAUDERDALE, Fla and SACRAMENTO, Calif. — Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson to its Board of Directors. [...]

Access IBO on Knowledge Center